Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Armstrong, Gregory

St. Jude Children'S Research Hospital
United States

Sen-Survivors: An open-label intervention trial for frailty and senescence 1U01CA246510-01 Eileen Dimond, R.N., M.S.
Arnold, Corey Wells

University Of California Los Angeles
United States

Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification 5R01CA279666-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-03 Winfred Malone, Ph.D., M.P.H.
Azizoddin, Desiree R

Dana-Farber Cancer Inst
United States

Leveraging mHealth to deliver integrated pain-CBT, opioid monitoring, and self-management support for advanced cancer patients coping with chronic pain 7R21CA263838-03 Brennan Streck, Ph.D., RN, M.P.H.
Badu-Tawiah, Abraham

Ohio State University
United States

Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening 5R21CA270727-02 PAR-20-292 (R21 Clinical Trial Optional) Claire Zhu, Ph.D.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.
Bae-Jump, Victoria Lin

Univ Of North Carolina Chapel Hill
United States

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer 5R37CA226969-07 Goli Samimi, Ph.D., M.P.H.
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 5UG1CA189971-11 Vanessa A. White, M.P.H.
Balskus, Emily Patricia

Harvard University
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 1OT2CA297577-01 Asad Umar, D.V.M., Ph.D.
Balu, Mihaela

University Of California-Irvine
United States

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma 5R01CA259019-03 PAR-20-155 (R01 Clinical Trial Optional) Richard Mazurchuk, Ph.D.